SLU-PP-332 is a selective sigma-2 receptor ligand with nanomolar affinity, demonstrating potent cytotoxic activity against cancer cells while showing neuroprotective effects in neurodegenerative models. This bifunctional compound represents a unique research tool for investigating sigma-2 receptor pharmacology, cancer cell apoptosis mechanisms, and neurodegenerative disease pathology. Our research-grade SLU-PP-322 enables exploration of sigma-2 receptor-mediated cell death pathways, cholesterol homeostasis modulation, and potential therapeutic applications in oncology and neurology research.